Omar A. Almohammed

1.0k total citations
71 papers, 606 citations indexed

About

Omar A. Almohammed is a scholar working on Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism and Surgery. According to data from OpenAlex, Omar A. Almohammed has authored 71 papers receiving a total of 606 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Cardiology and Cardiovascular Medicine, 12 papers in Endocrinology, Diabetes and Metabolism and 11 papers in Surgery. Recurrent topics in Omar A. Almohammed's work include Venous Thromboembolism Diagnosis and Management (11 papers), Atrial Fibrillation Management and Outcomes (10 papers) and Diabetes Treatment and Management (10 papers). Omar A. Almohammed is often cited by papers focused on Venous Thromboembolism Diagnosis and Management (11 papers), Atrial Fibrillation Management and Outcomes (10 papers) and Diabetes Treatment and Management (10 papers). Omar A. Almohammed collaborates with scholars based in Saudi Arabia, United States and Jordan. Omar A. Almohammed's co-authors include Osamah M. Alfayez, Majed S. Al Yami, Abdulaali R. Almutairi, Yazed AlRuthia, Yousif A. Asiri, Faleh Alqahtani, Sary Alsanea, Leanne Lai, Faisal F. Alamri and Nasser M. Alqahtani and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Diabetes.

In The Last Decade

Omar A. Almohammed

59 papers receiving 597 citations

Peers

Countries citing papers authored by Omar A. Almohammed

Since Specialization

Citations

This map shows the geographic impact of Omar A. Almohammed's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Omar A. Almohammed with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Omar A. Almohammed more than expected).

Fields of papers citing papers by Omar A. Almohammed

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Omar A. Almohammed. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Omar A. Almohammed. The network helps show where Omar A. Almohammed may publish in the future.

Co-authorship network of co-authors of Omar A. Almohammed

This figure shows the co-authorship network connecting the top 25 collaborators of Omar A. Almohammed. A scholar is included among the top collaborators of Omar A. Almohammed based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Omar A. Almohammed. Omar A. Almohammed is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Identification of potential novel aromatase inhibitors as therapeutic strategies against breast cancer: insight into molecular docking, MD simulations and ADMET profiling 2025 ·BMC Cancer ·(unknown), (unknown), (unknown), (unknown), (unknown), Omar A. Almohammed	0
2	Identification of novel DYRK1A inhibitors as treatment options for alzheimer’s disease through comprehensive in silico approaches 2025 ·Scientific Reports ·(unknown), (unknown), Neeraj Kumar, (unknown), Haruna Isiyaku Umar, (unknown), (unknown), (unknown), Abdullahi Tunde Aborode, (unknown), (unknown), Mohammad Khalid, Omar A. Almohammed	0
3	Evaluating the risk of acute kidney injury and mortality associated with concomitant use of vancomycin with piperacillin/tazobactam or meropenem in critically ill and non-critically ill patients: a systematic review and meta-analysis 2025 ·BMC Infectious Diseases ·(unknown), Majed S. Al Yami, Atheer Aldairem, (unknown), Abdulaali R. Almutairi, Omar A. Almohammed, (unknown)	0
4	Prevalence of depression, anxiety, and stigma among high school students with deafness and its association with their quality of school life: A national study from Saudi Arabia 2024 ·Research in Developmental Disabilities ·(unknown), Omar A. Almohammed	0
5	The association between tocilizumab therapy and the development of thrombosis in critically ill patients with COVID-19: a multicenter, cohort study 2024 ·Scientific Reports ·Ohoud Aljuhani, Khalid Al Sulaiman, Ghazwa B. Korayem, Ali F. Altebainawi, (unknown), (unknown), (unknown), Aisha Alharbi, (unknown), (unknown), (unknown), Omar A. Almohammed, (unknown), (unknown), (unknown), (unknown), (unknown), Ramesh Vishwakarma	4
6	Effectiveness and Safety of GLP-1 Receptor Agonists in Patients with Type 1 Diabetes 2024 ·Journal of Clinical Medicine ·Sumaya N. Almohareb, Osamah M. Alfayez, (unknown), (unknown), (unknown), Mohammed Kanan Alshammari, Majed S. Al Yami, Omar A. Alshaya, (unknown), Ghazwa B. Korayem, Omar A. Almohammed	6
7	Assessment of Knowledge and Practice of Healthcare Providers in Saudi Arabia Regarding Clostridioides difficile Infection Diagnosis and Management: A Cross-Sectional Questionnaire-Based Study 2024 ·Infection and Drug Resistance ·Masaad Saeed Almutairi, (unknown), (unknown), (unknown), Omar A. Almohammed, Abrar K. Thabit	2
8	Evaluating the use of paracetamol to prevent fasting headache during the first week of Ramadan: A randomized, open‐label, clinical trial 2024 ·Headache The Journal of Head and Face Pain ·Omar A. Almohammed, Sary Alsanea, (unknown), (unknown), (unknown), (unknown), Fawaz Alasmari, (unknown), Mohammed A. Assiri, (unknown), (unknown), (unknown), Abdulrahman Alwhaibi	2
9	Effect of fasting-induced headache on calcitonin gene related peptide (CGRP) and other clinical biomarkers on the first day of Ramadan: Sub-analysis from a randomized open label clinical trial 2024 ·The Journal of Headache and Pain ·Abdulrahman Alwhaibi, Fawaz Alasmari, (unknown), Mohammed A. Assiri, (unknown), (unknown), (unknown), (unknown), (unknown), Omar A. Almohammed, Sary Alsanea	2
10	The Perils of Methanol Exposure: Insights into Toxicity and Clinical Management 2024 ·Toxics ·Mohammed Alrashed, (unknown), (unknown), (unknown), (unknown), Tariq Alqahtani, (unknown), (unknown), Sultan Alghadeer, (unknown), (unknown), Omar A. Almohammed	10
11	Public awareness of online pharmacies, consumers’ motivating factors, experience and satisfaction with online pharmacy services, and current barriers and motivators for non-consumers: The case of Saudi Arabia 2023 ·Saudi Pharmaceutical Journal ·Omar A. Almohammed, (unknown), (unknown), (unknown), (unknown), Norah O. Abanmy	7
12	Associations of Depression and Anxiety with Stigma in a Sample of Patients in Saudi Arabia Who Recovered from COVID-19 2022 ·SHILAP Revista de lepidopterología ·(unknown), Omar A. Almohammed, Faleh Alqahtani, Yazed AlRuthia	15
13	Demographic Characteristics and Status of Vaccinated Individuals with a History of COVID-19 Infection Pre- or Post-Vaccination: A Descriptive Study of a Nationally Representative Sample in Saudi Arabia 2022 ·Vaccines ·Yazed AlRuthia, (unknown), Omar A. Almohammed, Amani S. Alqahtani, (unknown), ‏Yousef Alsofayan, Sami Almudarra, (unknown), (unknown), Khaled Alabdulkareem, Bander Balkhi, (unknown), Abdullah Salah Alanazi, Yousif A. Asiri	1
14	Validation and Cultural Adaptation of Explanatory Model Interview Catalogue (EMIC) in Assessing Stigma among Recovered Patients with COVID-19 in Saudi Arabia 2021 ·International Journal of Environmental Research and Public Health ·(unknown), (unknown), (unknown), (unknown), Faisal F. Alamri, Faleh Alqahtani, Amer S. Alali, Omar A. Almohammed, Yousif A. Asiri, (unknown), Yazed AlRuthia	10
15	The Impact of COVID-19 on Essential Medicines and Personal Protective Equipment Availability and Prices in Saudi Arabia 2021 ·Healthcare ·(unknown), Yazed AlRuthia, Bander Balkhi, Ibrahim Sales, Monira Alwhaibi, Omar A. Almohammed, (unknown), (unknown), Yousif A. Asiri	35
16	Real-World Effectiveness and Safety of Apixaban versus Warfarin in Patients with Acute Venous Thromboembolism: Experience of a Large Tertiary Hospital in Saudi Arabia 2021 ·International Journal of General Medicine ·Majed S. Al Yami, (unknown), (unknown), Omar A. Alshaya, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Ghazwa B. Korayem, Osamah M. Alfayez, Abdulaali R. Almutairi, Omar A. Almohammed	5
17	Patients’ Behavior Regarding Dietary or Herbal Supplements before and during COVID-19 in Saudi Arabia 2021 ·International Journal of Environmental Research and Public Health ·(unknown), (unknown), Faisal F. Alamri, Yazed AlRuthia, Faleh Alqahtani, Omer I. Fantoukh, (unknown), Omar A. Almohammed	40
18	Association of Healthy Diet with Recovery Time from COVID-19: Results from a Nationwide Cross-Sectional Study 2021 ·International Journal of Environmental Research and Public Health ·Faisal F. Alamri, Aslam Khan, (unknown), (unknown), (unknown), (unknown), (unknown), Omar A. Almohammed, Ahmad Mohammad Salamatullah, Amer S. Alali, (unknown), (unknown), Yazed AlRuthia, Faleh Alqahtani	3
19	Public Perception and Attitude toward Community Pharmacists in Saudi Arabia 2021 ·Omar A. Almohammed, Sary Alsanea	18
20	Safety and effectiveness of thromboprophylaxis use in hospitalized elderly medical patients at a Saudi tertiary care center 2021 ·Saudi Pharmaceutical Journal ·Ghazwa B. Korayem, Omar A. Alshaya, (unknown), (unknown), Omar A. Almohammed, Osamah M. Alfayez, Majed S. Al Yami	0

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact